Utah Medical Products INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Utah Medical Products, Inc. (UTMD) has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
Utah Medical Products (UTMD) is set to hold its 2025 Annual Meeting of Stockholders, focusing on the election of a new director, ratification of the accounting firm, and an advisory vote on executive compensation.
NASDAQ
Utah Medical Products, Inc. has issued a supplement to its definitive proxy statement to correct the language for proposal 3 regarding executive compensation, ahead of the 2024 Annual Meeting of Stockholders.
NASDAQ
Utah Medical Products, Inc. is holding its annual stockholder meeting on May 3, 2024, to vote on the re-election of two directors, ratify the selection of its accounting firm, and conduct an advisory vote on executive compensation.